The Carlyle Group LP Aktie
WKN DE: A1JXD8 / ISIN: US14309L1026
19.10.2020 16:48:00
|
Albany Molecular Research, Inc. -- Moody's upgrades AMRI's CFR to B2; affirms first lien ratings at B2; outlook stable
Rating Action: Moody's upgrades AMRI's CFR to B2; affirms first lien ratings at B2; outlook stableVollständigen Artikel bei Moodys lesen